Hirohisa Ogawa

2.0k total citations
89 papers, 1.6k citations indexed

About

Hirohisa Ogawa is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Hirohisa Ogawa has authored 89 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 22 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Hirohisa Ogawa's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Asthma and respiratory diseases (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Hirohisa Ogawa is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Asthma and respiratory diseases (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Hirohisa Ogawa collaborates with scholars based in Japan, United States and United Kingdom. Hirohisa Ogawa's co-authors include Saburo Sone, Hisanori Uehara, Hisatsugu Goto, Yasuhiko Nishioka, Keisuke Izumi, Seiji Yano, Koichi Tsuneyama, Tetsuyuki Takahashi, Takaaki Tsunematsu and Yuki Morimoto and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Hirohisa Ogawa

85 papers receiving 1.6k citations

Peers

Hirohisa Ogawa
Anthony D. Kang United States
Zaoqu Liu China
Yue Yu China
Chao Qian China
Xinguo Jiang United States
Ning Ding China
Anthony D. Kang United States
Hirohisa Ogawa
Citations per year, relative to Hirohisa Ogawa Hirohisa Ogawa (= 1×) peers Anthony D. Kang

Countries citing papers authored by Hirohisa Ogawa

Since Specialization
Citations

This map shows the geographic impact of Hirohisa Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirohisa Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirohisa Ogawa more than expected).

Fields of papers citing papers by Hirohisa Ogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirohisa Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirohisa Ogawa. The network helps show where Hirohisa Ogawa may publish in the future.

Co-authorship network of co-authors of Hirohisa Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hirohisa Ogawa. A scholar is included among the top collaborators of Hirohisa Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirohisa Ogawa. Hirohisa Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sato, Seidai, Takeshi Masuda, Hirokazu Ogino, et al.. (2024). A case of pleural mesothelioma with immunohistochemical staining positive for Krebs von den Lungen-6. Respiratory Medicine Case Reports. 50. 102040–102040.
2.
Hosokawa, Masato, et al.. (2023). Accumulation of α-synuclein in hepatocytes in nonalcoholic steatohepatitis and its usefulness in pathological diagnosis. Pathology - Research and Practice. 247. 154525–154525. 4 indexed citations
3.
Ichimura‐Shimizu, Mayuko, Hirohisa Ogawa, Satoko Nakamura, et al.. (2023). Establishment of repeated liver biopsy technique in experimental mice. Heliyon. 9(6). e16978–e16978. 1 indexed citations
4.
Sato, Seidai, Kazuya Koyama, Hirohisa Ogawa, et al.. (2023). A novel BRD4 degrader, ARV-825, attenuates lung fibrosis through senolysis and antifibrotic effect. Respiratory Investigation. 61(6). 781–792. 7 indexed citations
5.
MATSUMOTO, Ryosuke, et al.. (2022). A rare case of fibrohistiocytic hepatic inflammatory pseudotumor with cholecystocholangitis showing positive IgG4 staining. Clinical Journal of Gastroenterology. 15(5). 975–980. 3 indexed citations
6.
Ichimura‐Shimizu, Mayuko, Christine Wai, Takeo Minamikawa, et al.. (2022). Establishment of an Epicutaneously Sensitized Murine Model of Shellfish Allergy and Evaluation of Skin Condition by Raman Microscopy. Applied Sciences. 12(7). 3566–3566.
7.
Ogawa, Hirohisa, et al.. (2021). Early gastric cancer with lanthanum deposition mucosa by endoscopic submucosal dissection: a case report and literature review. Clinical Journal of Gastroenterology. 14(5). 1344–1349. 1 indexed citations
8.
Takasu, Chie, Katsuki Miyazaki, Kozo Yoshikawa, et al.. (2021). Effect of TU‐100 on Peyer's patches in a bacterial translocation rat model. Annals of Gastroenterological Surgery. 5(5). 683–691. 3 indexed citations
9.
Sato, Seidai, Kazuya Koyama, Yajuan Chen, et al.. (2020). Blockade of Pan-Fibroblast Growth Factor Receptors Mediates Bidirectional Effects in Lung Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 63(3). 317–326. 8 indexed citations
10.
Kishi, Masami, Yoshinori Aono, Seidai Sato, et al.. (2018). Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice. PLoS ONE. 13(12). e0209786–e0209786. 40 indexed citations
11.
Koyama, Kazuya, Hisatsugu Goto, Seidai Sato, et al.. (2018). The Tyrosine Kinase Inhibitor TAS-115 Attenuates Bleomycin-induced Lung Fibrosis in Mice. American Journal of Respiratory Cell and Molecular Biology. 60(4). 478–487. 17 indexed citations
12.
Tsuneyama, Koichi, Kazuchika Nishitsuji, Minoru Matsumoto, et al.. (2017). Animal models for analyzing metabolic syndrome‐associated liver diseases. Pathology International. 67(11). 539–546. 29 indexed citations
13.
Kuramoto, Takuya, Hisatsugu Goto, Atsushi Mitsuhashi, et al.. (2012). Dll4-Fc, an Inhibitor of Dll4-Notch Signaling, Suppresses Liver Metastasis of Small Cell Lung Cancer Cells through the Downregulation of the NF-κB Activity. Molecular Cancer Therapeutics. 11(12). 2578–2587. 41 indexed citations
14.
Aono, Yoshinori, Julie G. Ledford, Sambuddho Mukherjee, et al.. (2011). Surfactant Protein-D Regulates Effector Cell Function and Fibrotic Lung Remodeling in Response to Bleomycin Injury. American Journal of Respiratory and Critical Care Medicine. 185(5). 525–536. 58 indexed citations
15.
Ogawa, Hirohisa. (2008). Present Infant Crisis and Challenges in Child Care. Early childhood education. 14(1). 23–32. 2 indexed citations
16.
Ogawa, Hirohisa, et al.. (2008). Laser‐induced formation of nonradiative centers observed by two‐wavelength excited photoluminescence. Physica status solidi. C, Conferences and critical reviews/Physica status solidi. C, Current topics in solid state physics. 5(9). 2929–2931. 3 indexed citations
18.
Ogawa, Hirohisa, et al.. (2005). [A case of pulmonary parenchymal endometriosis].. PubMed. 43(3). 165–70. 3 indexed citations
19.
Goto, Hisatsugu, Seiji Yano, Helong Zhang, et al.. (2002). Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice.. PubMed. 62(13). 3711–5. 72 indexed citations
20.
Ogawa, Hirohisa, Naoki Nishimura, Yasuhiko Nishioka, et al.. (2002). Interleukin (IL)-12 gene transduction and its functional expression into human bronchial epithelial cells (BEAS-2B) by adenovirus vector.. PubMed. 49(1-2). 74–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026